roche - Search News

Roche, Obesity and Zealand

Roche secures Zealand obesity drug candidate for up to $5.3 billion

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market.

Zacks.com on MSN · 1d

NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand

Novo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 billion with Denmark’s Zealand Pharma to co-develop its lead obesity candidate petrelintide.

AOL · 2d

Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4%

Roche is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma , the companies announced Wednesday. The deal would

Proactiv, La Roche-Posay and acne

CNN · 1d

Some La Roche-Posay, Proactiv and Walgreens acne treatments recalled due to benzene levels

U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government testing found they contain slightly elevated levels of a chemical associated with cancer.

USA TODAY · 7h

Acne treatments from brands such as Walgreens, La Roche-Posay, Proactiv are being recalled

ABC7 News · 10h

Skin care products from La Roche-Posay, Proactiv recalled over potentially cancer-causing chemical

The U.S. Food and Drug Administration issued a recall notice Tuesday for several lots of six products, including Walgreens Acne Control Cleanser, Proactiv Skin Smoothing Exfoliator, SLMD Benzoyl Peroxide Acne Lotion and La Roche-Posay Effaclar Duo Dual Action Acne Treatment.

Fierce Pharma3h

Roche settles UPenn suit alleging patent infringement by Herceptin, 3 other breast cancer meds

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed on its ...

2don MSN

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal

Roche Holding said it would pay Danish biotechnology research company Zealand Pharma up to $5.3 billion under an agreement to ...

BioSpace3d

Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit

In connection with Spark’s overhaul, Roche will incur approximately $2.4 billion in goodwill impairment costs. This sum takes ...

2don MSN

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Roche Diagnostics supports UK eye cancer AI initiative

Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

Analytics India Magazine11h

Inside Roche’s Leadership Formula for GCC Success in India

Roche’s work in India is powered by its digital centre of excellence, which Jamalamadaka mentioned “operates as an integral ...

Fierce Biotech2d

Roche pads out obesity pipeline, paying Zealand $1.6B upfront to codevelop amylin asset

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

ROCHE BOBOIS: MONTHLY NEWSLETTER - FEBRUARY 2025

Roche Bobois, the global leader in the high-end furniture market and the epitome of the French Art de Vivre, publishes its latest news every month. FEBRUARY 2025 LATEST NEWS PENINSULA PARIS ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Roche, Obesity and Zealand

Proactiv, La Roche-Posay and acne

Related topics